The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays (Q28208371)

0 references

Ralf G Meyer

0 references

Tanja Kreer

0 references

Thomas Wölfel

0 references

Wolfgang Herr

Journal of Immunological Methods

0 references

language of work or name

English

0 references

publication date

1 January 2002

0 references

published in

0 references

volume

259

0 references

issue

1-2

0 references

page(s)

95-110

0 references

cites work

PMA-treated K-562 leukemia cells mediate a TH2-specific expansion of CD4+ T cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Dendritic cells and the control of immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Presentation of viral antigen controlled by a gene in the major histocompatibility complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

The biochemistry and cell biology of antigen processing and presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Detection and quantification of blood-derived CD8+ T lymphocytes secreting tumor necrosis factor alpha in response to HLA-A2.1-binding melanoma and viral peptide antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Insect cells as HLA-restricted antigen-presenting cells for the IFN-gamma elispot assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Rapid effector function in CD8+ memory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Transporter (TAP)-independent processing of a multiple membrane-spanning protein, the Epstein-Barr virus latent membrane protein 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

CD28/B7 system of T cell costimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Costimulation of T-cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

The class I antigen-processing pathway for the membrane protein tyrosinase involves translation in the endoplasmic reticulum and processing in the cytosol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Identification of peptide sequences that potentially trigger HLA‐A2.1‐restricted cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Morphological and Functional Characterization of Isolated Effector Cells Responsible for Human Natural Killer Activity to Fetal Fibroblasts and to Cultured Cell Line Targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Analysis of the T cell response to tumor and viral peptide antigens by an IFNgamma-ELISPOT assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Roles of adhesion molecules in T-cell recognition: fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding, and costimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

HLA class I alleles of LCL 721 and 174 x CEM.T2 (T2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Analysis of antigens recognized on human melanoma cells by A2‐restricted cytolytic t lymphocytes (CTL)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

Transporter (TAP)- and proteasome-independent presentation of a melanoma-associated tyrosinase epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2801%2900499-9

10.1016/S0022-1759(01)00499-9

7 January 2021

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

11730845

1 reference

Consolidated OpenCitations Corpus – April 2017